Online Inquiry
Cat.#: ACPP-1265
| Despition | EDG8 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1617 | Human PARK2 Protein (AC1617) | 5 µg | inquiry |
| ACPP-1359 | iNOS Blocking Peptide (AC1359) | 250 µg | inquiry |
| ACPP-1705 | Human NXPH1 Protein (AC1705) | 5 µg | inquiry |
| ACPP-1426 | Human ENO2 Protein (AC1426) | 5 µg | inquiry |
| ACPP-1268 | Human LGALS3 Protein (AC1268) | 10 µg | inquiry |
| ACPP-1847 | Human GFRA3 Protein (AC1847) | 5 µg | inquiry |
| ACPP-1030 | Recombinant Human Acetylcholinesterase Protein (6×His Tag) (AC1030) | 50 µg | inquiry |
| ACPP-1213 | CACNB2 Blocking Peptide (AC1213) | 250 µg | inquiry |
| ACPP-1204 | P2Y1 Blocking Peptide (AC1204) | 250 µg | inquiry |
| ACPP-1347 | Human HDL Protein (AC1347) | 10 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.